Your Report.
A Patient’s Future.

The PD-L1 CPS score could unlock a patient’s treatment path.

PD-L1 CPS Train24 | Agilent

Select your remote session schedule

Please select only one training session.

Your Personal Data

* This field is required
For full details of how we will treat your information please view our privacy policy: www.agilent.com/home/privacy-policy

Increase your confidence in PD-L1 CPS scoring with our informative remote sessions

PD-L1 status directly impacts a patient’s potential treatment. In this course you will learn and improve your CPS technique for scoring PD-L1 IHC 22C3 pharmDx stained slides using a comprehensive and systematic approach.

  • Head and Neck
  • Gastric or GEJ Adenocarcinoma
  • TNBC
  • Cervical
  • ESCC

2025 remote session schedule

January 23

11:00 am to 2:00 pm PT | 2:00 pm to 5:00 pm ET

February 19

11:00 am to 2:00 pm PT | 2:00 pm to 5:00 pm ET

Learning overview

  • 3 hour live interactive training
  • Course led by board certified pathologist with extensive CPS scoring experience
  • Discuss the application of the Combined Positive Score (CPS) with Agilent’s PD-L1 IHC 22C3 pharmDx assay
  • Simplify the CPS approach to enable pathologists to confidently assess and apply the algorithm
  • Interactive case walkthrough